IBCL-117 ASPEN: Long-Term Follow-Up Results of a Phase 3 Randomized Trial of Zanubrutinib vs Ibrutinib in Patients With Waldenström Macroglobulinemia
- Castillo, J.J.
- Tam, C.S.
- Garcia-Sanz, R.
- Opat, S.
- D'Sa, S.
- Jurczak, W.
- Lee, H.-P.
- Cull, G.
- Owen, R.G.
- Marlton, P.
- Wahlin, B.E.
- Tedeschi, A.
- Siddiqi, T.
- Buske, C.
- Leblond, V.
- Chan, W.Y.
- Schneider, J.
- Cohen, A.
- Dimopoulos, M.
ISSN: 2152-2669, 2152-2650
Ano de publicación: 2022
Volume: 22
Páxinas: S385
Tipo: Artigo